Annapoorni Rangarajan
Recent studies have identified a small subpopulation of cells within several cancers termed as cancer stem cells (CSCs). These CSCs play critical roles in tumor initiation, progression, and maintenance. Furthermore, CSCs remain unaffected by currently used chemotherapeutic drugs, thereby leading to chemotherapy failure and cancer recurrence. The research focus of my laboratory is to understand the unique molecular mechanisms operating within CSCs, and find novels ways for targeting them. Work done in my laboratory has identified AMP activated protein kinase (AMPK) as a key signaling molecule in the regulation of breast cancer stem-like properties, survival and drug resistance. Current interests are in understanding the molecular mechanisms downstream of AMPK activation that contribute to cancer progression.
